BTK mutations in patients with chronic lymphocytic leukemia receiving tirabrutinib

被引：6

作者：

Jackson, Ross A. ^{[1
]}

Britton, Robert G. ^{[2
,3
]}

Jayne, Sandrine ^{[1
]}

Lehmann, Susann ^{[4
]}

Cowley, Caroline M. ^{[5
]}

Trethewey, Christopher S. ^{[1
]}

Smith, Victoria M. ^{[1
]}

Schmid, Ralf ^{[6
]}

Fegan, Christopher ^{[7
]}

Walter, Harriet S. ^{[1
]}

Dyer, Martin J. S. ^{[1
,8
]}

机构：

[1] Leicester Canc Res Ctr, Ernest & Helen Scott Haematol Res Inst, Dept Genet & Genome Biol, Leicester, England

[2] Leicester Canc Res Ctr, Dept Genet & Genome Biol, Leicester, England

[3] Leicester Canc Res Ctr, Dept Chem, Leicester, England

[4] Leicester Canc Res Ctr, Inst Precis Hlth, Leicester Drug Discovery & Diagnost, Leicester, England

[5] Leicester Canc Res Ctr, Leicester Mol Diagnost, Dept Genet & Genome Biol, Leicester, England

[6] Univ Leicester, Dept Mol & Cell Biol, Leicester, England

[7] Univ Hosp Wales, Cardiff, Wales

[8] Univ Leicester, Ernest & Helen Scott Haematol Res Inst, Dept Genet & Genome Biol, Henry Wellcome Bldg Room 3-57,Lancaster Rd, Leicester LE1 9HN, England

来源：

BLOOD ADVANCES | 2023年 / 7卷 / 14期

关键词：

IBRUTINIB; RESISTANCE; PIRTOBRUTINIB; MECHANISMS;

D O I：

10.1182/bloodadvances.2022009366

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：3378 / 3381

页数：4

共 16 条

[1] Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemia [J].

Ahn, Inhye E. ;

Underbayev, Chingiz ;

Albitar, Adam ;

Herman, Sarah E. M. ;

Tian, Xin ;

Maric, Irina ;

Arthur, Diane C. ;

Wake, Laura ;

Pittaluga, Stefania ;

Yuan, Constance M. ;

Stetler-Stevenson, Maryalice ;

Soto, Susan ;

Valdez, Janet ;

Nierman, Pia ;

Lotter, Jennifer ;

Xi, Liqiang ;

Raffeld, Mark ;

Farooqui, Mohammed ;

Albitar, Maher ;

Wiestner, Adrian .

BLOOD, 2017, 129 (11) :1469-1479

[2] Enrichment of BTK Leu528Trp mutations in patients with CLL on zanubrutinib: potential for pirtobrutinib cross-resistance [J].

Blombery, Piers ;

Thompson, Ella R. ;

Lew, Thomas E. ;

Tiong, Ing Soo ;

Bennett, Rory ;

Cheah, Chan Y. ;

Lewis, Katharine Louise ;

Handunnetti, Sasanka M. ;

Tang, Chloe Pek Sang ;

Roberts, Andrew ;

Seymour, John F. ;

Tam, Constantine S. .

BLOOD ADVANCES, 2022, 6 (20) :5589-5592

[3] Kinase-deficient BTK mutants confer ibrutinib resistance through activation of the kinase HCK [J].

Dhami, Kamaldeep ;

Chakraborty, Anirban ;

Gururaja, Tarikere L. ;

Cheung, Leo W. K. ;

Sun, Chaohong ;

DeAnda, Felix ;

Huang, XiaoDong .

SCIENCE SIGNALING, 2022, 15 (736)

[4] Dissection of subclonal evolution by temporal mutation profiling in chronic lymphocytic leukemia patients treated with ibrutinib [J].

Gango, Ambrus ;

Alpar, Donat ;

Galik, Bence ;

Marosvari, Dora ;

Kiss, Richard ;

Fesus, Viktoria ;

Aczel, Dora ;

Eyupoglu, Ediz ;

Nagy, Noemi ;

Nagy, Akos ;

Krizsan, Szilvia ;

Reiniger, Lilla ;

Farkas, Peter ;

Kozma, Andras ;

Adam, Emma ;

Tasnady, Szabolcs ;

Reti, Marienn ;

Matolcsy, Andras ;

Gyenesei, Attila ;

Matrai, Zoltan ;

Bodor, Csaba .

INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (01) :85-93

[5] BTK Leu528Trp-a Potential Secondary Resistance Mechanism Specific for Patients with Chronic Lymphocytic Leukemia Treated with the Next Generation BTK Inhibitor Zanubrutinib [J].

Handunnetti, Sasanka M. ;

Tang, Chloe Pek Sang ;

Tamia Nguyen ;

Zhou, Xing ;

Thompson, Ella ;

Sun, Hanzi ;

Xing, Haimei ;

Zhang, Bo ;

Guo, Yin ;

Sutton, Lesley Ann ;

Ghia, Paolo ;

Rosenquist, Richard ;

Scarfo, Lydia ;

Bonfiglio, Silvia ;

Seymour, John F. ;

Anderson, Mary Ann ;

Roberts, Andrew W. ;

Huang, David C. S. ;

Liu, Ye ;

Cheah, Chan Y. ;

Westerman, David Alan ;

Yeh, Paul Sung-Hao ;

Tam, Constantine S. ;

Blombery, Piers .

BLOOD, 2019, 134

[6] Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL [J].

Kadri, Sabah ;

Lee, Jimmy ;

Fitzpatrick, Carrie ;

Galanina, Natalie ;

Sukhanova, Madina ;

Venkataraman, Girish ;

Sharma, Shruti ;

Long, Brad ;

Petras, Kristin ;

Theissen, Megan ;

Ming, Mei ;

Kobzev, Yuri ;

Kang, Wenjun ;

Guo, Ailin ;

Wang, Weige ;

Niu, Nifang ;

Weiner, Howard ;

Thirman, Michael ;

Stock, Wendy ;

Smith, Sonali M. ;

Nabhan, Chadi ;

Segal, Jeremy P. ;

Lu, Pin ;

Wang, Y. Lynn .

BLOOD ADVANCES, 2017, 1 (12) :715-727

[7] Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia [J].

Maddocks, Kami J. ;

Ruppert, Amy S. ;

Lozanski, Gerard ;

Heerema, Nyla A. ;

Zhao, Weiqiang ;

Abruzzo, Lynne ;

Lozanski, Arletta ;

Davis, Melanie ;

Gordon, Amber ;

Smith, Lisa L. ;

Mantel, Rose ;

Jones, Jeffrey A. ;

Flynn, Joseph M. ;

Jaglowski, Samantha M. ;

Andritsos, Leslie A. ;

Awan, Farrukh ;

Blum, Kristie A. ;

Grever, Michael R. ;

Johnson, Amy J. ;

Byrd, John C. ;

Woyach, Jennifer A. .

JAMA ONCOLOGY, 2015, 1 (01) :80-87

[8]

Mato AR, 2021, LANCET, V397, P892, DOI 10.1016/S0140-6736(21)00224-5

[9] Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance [J].

Naeem, Aishath ;

Utro, Filippo ;

Wang, Qing ;

Cha, Justin ;

Vihinen, Mauno ;

Martindale, Stephen ;

Zhou, Yinglu ;

Ren, Yue ;

Tyekucheva, Svitlana ;

Kim, Annette S. ;

Fernandes, Stacey M. ;

Saksena, Gordon ;

Rhrissorrakrai, Kahn ;

Levovitz, Chaya ;

Danysh, Brian P. ;

Slowik, Kara ;

Jacobs, Raquel A. ;

Davids, Matthew S. ;

Lederer, James A. ;

Zain, Rula ;

Smith, C. I. Edvard ;

Leshchiner, Ignaty ;

Parida, Laxmi ;

Getz, Gad ;

Brown, Jennifer R. .

BLOOD ADVANCES, 2023, 7 (09) :1929-1943

[10]

Thompson ER, 2020, BLOOD, V136, P15, DOI [10.1182/blood-2020-137411, DOI 10.1182/BLOOD-2020-137411]

← 1 2 →